Adenosine Kinase

腺苷激酶 (AK) 是一种胞浆酶,可催化腺苷转化为 AMP。腺苷激酶是一种潜在的腺苷调节剂 (ARA) 靶标。腺苷激酶激活是腺苷的主要清除途径,也是其血浆半衰期极短(<1 秒)的部分原因。抑制腺苷激酶会导致细胞内腺苷增加,腺苷通过被动扩散或核苷转运体离开细胞,从而激活附近的细胞表面腺苷受体。因此,腺苷激酶抑制可以代表激活腺苷受体和产生腺苷相关药理学的替代机制。

腺苷激酶抑制剂 (AKI) 代表了一种替代策略,因为 AKI 可以以更针对部位和事件的方式提高局部腺苷水平,从而以更大的治疗窗口引发所需的药理学。几种有效的 AKI 在大鼠最大电击 (MES) 诱发的癫痫发作试验中表现出抗惊厥活性。

Adenosine kinase (AK) is a cytosolic enzyme that catalyzes the conversion of adenosine to AMP. One potential adenosine regulating agent (ARA) target is adenosine kinase. Adenosine kinase activation represents the major clearance route of adenosine and is partly responsible for its extremely short plasma half-life (<1 s). Inhibition of adenosine kinase results in increased intracellular adenosine which passes out of the cell via passive diffusion or via nucleoside transporter(s) to activate nearby cell-surface adenosine receptors. Thus, adenosine kinase inhibition can represent an alternative mechanism for activation of adenosine receptors and production of adenosine-associated pharmacologies.

Adenosine kinase inhibitors (AKIs) represent an alternative strategy, since AKIs may raise local adenosine levels in a more site- and event-specific manner and thereby elicit the desired pharmacology with a greater therapeutic window. Several potent AKIs are shown to exhibit anticonvulsant activity in the rat maximal electric shock (MES) induced seizure assay.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Antiparasitic agent-30

Antiparasitic agent-30 是一种高效的腺苷激酶 TbrAK 调节剂和抗锥虫剂,对罗德西亚锥虫表现出显著抑制活性,并能增强重组 TbrAK 的活性 (EC50=38 nM,Ka=75 nM-497 nM),其通过消除固有底物抑制作用过度激活罗德西亚锥虫的 TbrAK 从而发挥药效,可作为研究急性型非洲人类锥虫病 (昏睡病) 的重要工具分子。

671754-20-4
Activator
Antiparasitic agent-30

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础